USD 2.79
(-0.36%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -1.34 Million USD | -126.29% |
2022 | 5.1 Million USD | 106.49% |
2021 | -78.6 Million USD | -764.47% |
2020 | 11.82 Million USD | 12.44% |
2019 | 10.52 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -7.15 Million USD | -433.41% |
2024 Q2 | -3.51 Million USD | 50.86% |
2023 Q2 | -9.1 Million USD | 42.4% |
2023 Q3 | -2.9 Million USD | 68.14% |
2023 Q1 | -15.8 Million USD | -409.8% |
2023 FY | -1.34 Million USD | -126.29% |
2023 Q4 | -1.34 Million USD | 53.76% |
2022 Q3 | -4.58 Million USD | 76.83% |
2022 Q4 | 5.1 Million USD | 211.16% |
2022 FY | 5.1 Million USD | 106.49% |
2022 Q1 | -48.37 Million USD | 38.45% |
2022 Q2 | -19.8 Million USD | 59.07% |
2021 Q3 | -84.84 Million USD | -424.28% |
2021 FY | -78.6 Million USD | -764.47% |
2021 Q4 | -78.6 Million USD | 7.36% |
2021 Q2 | 26.16 Million USD | -14.7% |
2021 Q1 | 30.67 Million USD | 159.29% |
2020 FY | 11.82 Million USD | 12.44% |
2020 Q2 | -25 Thousand USD | -100.21% |
2020 Q3 | -1.43 Million USD | -5654.5% |
2020 Q1 | 11.73 Million USD | 0.0% |
2020 Q4 | 11.82 Million USD | 922.24% |
2019 FY | 10.52 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Abbott Laboratories | 8.97 Billion USD | 100.015% |
Allurion Technologies Inc. | 3.82 Million USD | 135.105% |
Artivion, Inc. | 300.4 Million USD | 100.446% |
Avanos Medical, Inc. | 121.4 Million USD | 101.105% |
Butterfly Network, Inc. | -109.6 Million USD | 98.777% |
Butterfly Network, Inc. | -109.6 Million USD | 98.777% |
Bio-Rad Laboratories, Inc. | 1 Billion USD | 100.134% |
Boston Scientific Corporation | 8.62 Billion USD | 100.016% |
CONMED Corporation | 966.95 Million USD | 100.139% |
Edwards Lifesciences Corporation | -449.1 Million USD | 99.701% |
Paragon 28, Inc. | 36.39 Million USD | 103.685% |
Glaukos Corporation | 290.27 Million USD | 100.462% |
Globus Medical, Inc. | 53.11 Million USD | 102.525% |
Inspire Medical Systems, Inc. | -160.69 Million USD | 99.165% |
Integer Holdings Corporation | 1.01 Billion USD | 100.132% |
Medtronic plc | 24.76 Billion USD | 100.005% |
Myomo, Inc. | -6.27 Million USD | 78.612% |
Nevro Corp. | 117.61 Million USD | 101.14% |
Penumbra, Inc. | 66.85 Million USD | 102.006% |
Vicarious Surgical Inc. | -37.99 Million USD | 96.47% |
Smith & Nephew plc | 2.78 Billion USD | 100.048% |
Sonendo, Inc. | 26.34 Million USD | 105.091% |
STERIS plc | 3.17 Billion USD | 100.042% |
Stryker Corporation | 10.02 Billion USD | 100.013% |
Vapotherm, Inc. | 102.66 Million USD | 101.306% |
Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 100.024% |